Literature DB >> 9725219

Distinct stage-specific cis-active transcriptional mechanisms control expression of T cell coreceptor CD8 alpha at double- and single-positive stages of thymic development.

X L Zhang1, R Seong, R Piracha, M Larijani, M Heeney, J R Parnes, J W Chamberlain.   

Abstract

Developing thymocytes that give rise to CD8+ (cytotoxic) and CD4+ (helper) alpha beta-TCR T lymphocytes go through progressive stages of expression of coreceptors CD8 and CD4 from being negative for both (the double-negative stage), to coexpressing both (the double-positive (DP) stage), to a mutually exclusive sublineage-specific expression of one or the other (the single-positive (SP) stage). To delineate the mechanisms underlying regulation of CD8 during these developmental transitions, we have examined expression of a series of mouse CD8 alpha gene constructs in developing T cells of conventional and CD8 alpha "knock-out" transgenic mice. Our results indicate that cis-active transcriptional control sequences essential for stage- and sublineage-specific expression lie within a 5' 40-kb segment of the CD8 locus, approximately 12 kb upstream of the CD8 alpha gene. Studies to characterize and sublocalize these cis sequences showed that a 17-kb 5' subfragment is able to direct expression of the CD8 alpha gene up to the CD3intermediate DP stage but not in more mature DP or SP cells. These results indicate that stage-specific expression of CD8 alpha in developing T cells is mediated by the differential activity of multiple functionally distinct cis-active transcriptional control mechanisms. It will be important to determine the relationship of "switching" between these cis mechanisms and selection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725219

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  cAMP-responsive element modulator α (CREMα) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease.

Authors:  Christian M Hedrich; Thomas Rauen; Jose C Crispin; Tomohiro Koga; Christina Ioannidis; Melissa Zajdel; Vasileios C Kyttaris; George C Tsokos
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

2.  cAMP responsive element modulator (CREM) α mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells.

Authors:  Christian M Hedrich; José C Crispín; Thomas Rauen; Christina Ioannidis; Tomohiro Koga; Noe Rodriguez Rodriguez; Sokratis A Apostolidis; Vasileios C Kyttaris; George C Tsokos
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

Review 3.  The epigenetic landscape of lineage choice: lessons from the heritability of CD4 and CD8 expression.

Authors:  Manolis Gialitakis; Maclean Sellars; Dan R Littman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

4.  Expression of the mouse pre-T cell receptor alpha gene is controlled by an upstream region containing a transcriptional enhancer.

Authors:  B Reizis; P Leder
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

5.  CD8 expression up to the double-positive CD3(low/intermediate) stage of thymic differentiation is sufficient for development of peripheral functional cytotoxic T lymphocytes.

Authors:  X L Zhang; S Zhao; S H Borenstein; Y Liu; B Jayabalasingham; J W Chamberlain
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

Review 6.  Transcriptional control of CD4 and CD8 coreceptor expression during T cell development.

Authors:  Wilfried Ellmeier; Lena Haust; Roland Tschismarov
Journal:  Cell Mol Life Sci       Date:  2013-06-21       Impact factor: 9.261

7.  Development of all CD4 T lineages requires nuclear factor TOX.

Authors:  Parinaz Aliahmad; Jonathan Kaye
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.